We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-11.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$842M
AUM Growth
-$295M
Cap. Flow
-$112M
Cap. Flow %
-13.31%
Top 10 Hldgs %
47.05%
Holding
143
New
42
Increased
27
Reduced
21
Closed
50

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$14M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$11.9M
3
AMRN
Amarin Corp
AMRN
+$9.5M
4
SIBN icon
SI-BONE Inc
SIBN
+$9.49M
5
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$7.51M

Top Sells

Rank Stock Value
1
GRFS
Grifois
GRFS
+$13.5M
2
AGN
Allergan plc
AGN
+$13.3M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$7.52M
4
CNMD icon
CONMED
CNMD
+$5.18M
5
AXNX
Axonics, Inc. Common Stock
AXNX
+$4.53M

Sector Composition

Rank Sector Weight
1 Healthcare 34.76%
2 Industrials 1.16%
3 Consumer Staples 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVCR icon
51
CALL
NovoCure
NVCR
$2.05B
$3.66M 0.44%
+54,400
New +$4.3M
PPD
52
DELISTED
PPD, Inc. Common Stock
PPD
$3.65M 0.43%
+205,000
New +$5.15M
DMTK
53
DELISTED
DermTech, Inc. Common Stock
DMTK
$3.48M 0.41%
+308,916
New +$3.79M
TXG icon
54
10x Genomics
TXG
$7.52B
$3.4M 0.4%
54,620
-32,720
-37% -$2.55M
CSTL icon
55
Castle Biosciences
CSTL
$960M
$3.31M 0.39%
+110,899
New +$3.35M
CERS icon
56
Cerus
CERS
$546M
$3.15M 0.37%
+676,321
New +$3.06M
STXS icon
57
Stereotaxis
STXS
$139M
$3.11M 0.37%
1,029,281
+785,178
+322% +$3.24M
MSON
58
DELISTED
Misonix Inc
MSON
$3.01M 0.36%
+320,000
New +$4.85M
IMVTU
59
DELISTED
Immunovant, Inc. Units
IMVTU
$2.9M 0.34%
175,010
+9,840
+6% +$190K
APYX icon
60
Apyx Medical
APYX
$126M
$2.52M 0.3%
702,449
+128,667
+22% +$864K
OTIC
61
DELISTED
Otonomy, Inc.
OTIC
$2.46M 0.29%
1,246,858
+106,695
+9% +$329K
AMRN
62
Amarin Corp
AMRN
$297M
$2.42M 0.29%
30,316
+28,591
+1,657% +$9.5M
IMMU
63
PUT
DELISTED
Immunomedics Inc
IMMU
$2.23M 0.27%
165,600
-52,400
-24% -$882K
AMRN
64
PUT
Amarin Corp
AMRN
$297M
$2.07M 0.25%
25,880
-6,820
-21% -$2.27M
NVRO
65
DELISTED
NEVRO CORP.
NVRO
$2M 0.24%
+20,000
New +$2.41M
ARDX icon
66
Ardelyx
ARDX
$1.03B
$1.84M 0.22%
323,641
+51,036
+19% +$347K
ITMR
67
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$1.8M 0.21%
+152,947
New +$2.08M
TGTX icon
68
TG Therapeutics
TGTX
$7.58B
$1.76M 0.21%
178,964
-98,675
-36% -$1.25M
RNAC icon
69
Cartesian Therapeutics
RNAC
$263M
$1.51M 0.18%
+20,825
New +$2.01M
OSUR icon
70
OraSure Technologies
OSUR
$259M
$1.45M 0.17%
+135,021
New +$966K
AUPH icon
71
Aurinia Pharmaceuticals
AUPH
$2.06B
$1.44M 0.17%
98,913
-168,137
-63% -$2.97M
NGNE icon
72
Neurogene
NGNE
$738M
$1.11M 0.13%
4,870
-1,539
-24% -$317K
ZBH icon
73
CALL
Zimmer Biomet
ZBH
$18.7B
$1.01M 0.12%
10,300
-57,680
-85% -$7.56M
HZNP
74
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$972K 0.12%
+32,816
New +$1.11M
GNLN icon
75
Greenlane Holdings
GNLN
$1.19M
– –
0
– –
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2020 Portfolio in Review

As of Q1 2020, Pura Vida Investments held 143 positions worth $842M, down 26% from $1.14B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments withdrew a net $112M in Q1 2020, closing 50 positions and reducing 21 holdings. Its most notable exit was Grifois, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Pura Vida Investments opened a new position in AtriCure worth $13.1M.

  • Pura Vida Investments's largest Q1 2020 buy was AtriCure: 388,994 shares worth $13.1M.
  • Pura Vida Investments added most to Alexion Pharmaceuticals in Q1 2020, an estimated $11.9M increase.
  • Pura Vida Investments's biggest Q1 2020 reduction was DexCom, cutting an estimated $4.46M.
  • Pura Vida Investments fully exited Grifois in Q1 2020, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $842M portfolio in Q1 2020.
  • Pura Vida Investments opened 42 new positions and closed 50 in Q1 2020.
  • Pura Vida Investments's portfolio value fell 26% quarter-over-quarter to $842M.

Based on Pura Vida Investments's 13F filing for Q1 2020, filed 15 May 2020.